Clinical study offer

🫁 Paid Pneumonia Clinical Trials

Browse recruiting pneumonia clinical trials across the United States. Find eligibility information, locations and research opportunities near you.

Loading...
Active Studies
Pneumonia
Condition

Active Clinical Trials for Pneumonia

Showing live studies from ClinicalTrials.gov. Data refreshes daily.

Loading studies...

Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.

About Pneumonia

Pneumonia is a lung infection causing inflammation of air sacs that fill with fluid or pus. Clinical trials investigate new antibiotics, vaccine strategies, and adjunctive therapies to improve outcomes and combat antimicrobial resistance.

Common Symptoms

Cough with phlegm, fever, chills, shortness of breath, chest pain when breathing deeply, fatigue, nausea, vomiting, confusion (especially in elderly)

Risk Factors

Age (very young or elderly), chronic diseases (asthma, COPD, diabetes), smoking, immunocompromised status, recent viral infection, hospitalization, aspiration

Treatment Overview

Treatment includes antibiotics for bacterial pneumonia, antiviral medications for viral pneumonia, oxygen therapy, and supportive care. Clinical trials explore novel antibiotics for resistant organisms, monoclonal antibodies against respiratory pathogens, and immune-modulating therapies.

Why Participate?

Pneumonia clinical trials are crucial for developing new treatments against drug-resistant bacteria and improving outcomes in vulnerable populations.

Related Conditions

States with Pneumonia Clinical Trials

Cities with Pneumonia Clinical Trials

Frequently Asked Questions About Pneumonia Clinical Trials

Pneumonia clinical trials test new antibiotics, antiviral medications, and immune therapies to treat lung infections more effectively. Studies address the growing challenge of antibiotic-resistant pneumonia.
Eligibility depends on pneumonia type (community-acquired, hospital-acquired), severity, causative organism, and underlying health conditions.
Compensation varies. Participants may receive $50-$150 per visit with study medications and monitoring provided at no cost during hospitalization.
Yes, participants receive close medical monitoring throughout treatment. All trials have safety protocols and participants can receive standard care if needed.